Unusual post-transplantation recurrence of focal segmental glomerulosclerosis which resolved with cyclosporine but not with sirolimus

Transplant International

Volumn 18, Issue 4, 2005, Pages 458-460

  Skhiri, Habib ^a   Morelon, Emmanuel ^a,b,c   Noel, Laure Hélène ^a   Mamzer Bruneel, Marie France ^a   Legendre, Christophe ^b   Peraldi, Marie Noëlle ^a   Kreis, Henri ^a  

^a HÔPITAL NECKER ENFANTS MALADES   (France)

^b SAINT LOUIS HOSPITAL   (France)

^c EDOUARD HERRIOT HOSPITAL   (France)

Author keywords

Cyclosporine; Focal segmental glomerulosclerosis; Recurrent glomerulonephritis; Renal transplantation; Sirolimus

Indexed keywords

AZATHIOPRINE; CORTICOSTEROID; CYCLOSPORIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; RAPAMYCIN; THYMOCYTE ANTIBODY; IMMUNOSUPPRESSIVE AGENT;

ADULT; ANAMNESIS; ARTICLE; CASE REPORT; CHRONIC ALLOGRAFT NEPHROPATHY; DRUG EFFECT; DRUG EFFICACY; DRUG MECHANISM; FOCAL GLOMERULOSCLEROSIS; GRAFT REJECTION; GRAFT SURVIVAL; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY TRANSPLANTATION; MALE; NEPHROTIC SYNDROME; PRIORITY JOURNAL; PROTEINURIA; RECURRENT DISEASE; TREATMENT OUTCOME; DRUG RESISTANCE; RETREATMENT;

ADULT; CYCLOSPORINE; DRUG RESISTANCE; GLOMERULOSCLEROSIS, FOCAL SEGMENTAL; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KIDNEY TRANSPLANTATION; MALE; RECURRENCE; RETREATMENT; SIROLIMUS; TREATMENT OUTCOME;

EID: 20444445998     PISSN: 09340874     EISSN: 14322277     Source Type: Journal    
DOI: 10.1111/j.1432-2277.2004.00054.x     Document Type: Article

References (10)

1. Korbet S, Schwartz M, Lewis E. Recurrent nephrotic syndrome in renal allograft. Am J Kidney Dis 1988; 11: 270.
2. Ramos E, Tisher C. Recurrent diseases in the kidney transplant. Am J Kidney Dis 1994; 24: 142.
3. Artero M, Biava C, Amend W, Tomlanovich S, Vincenti F. Recurrent focal glomerulosclerosis: natural history and response to therapy. Am J Med 1992; 92: 375.
4. Striegel J, Sibley R, Fryd D, Mauer S. Recurrence of focal segmental sclerosis in children following renal transplantation. Kidney Int 1986; 30: 44.
5. Baum M, Stablein D, Panzarino V, Tejani A, Harmon W, Alexander S. Loss of living donor renal allograft survival advantage in children with focal segmental glomerulosclerosis. Kidney Int 2001; 59: 328.
6. Cibrik D, Kaplan B, Campbell D, Kriesche H. Renal allograft survival in transplant recipients with focal segmental glomerulosclerosis. Am J Transplant 2003; 3: 64.
7. Korbet S, Genchi R, Borok R, Schwartz M. The racial prevalence of glomerular lesions in nephrotic adults. Am J Kidney Dis 1996; 27: 647.
8. Cattran D, Appel G, Hebert L, et al. A randomized trial of cyclosporine in patients with steroid-resistant focal segmental glomerulosclerosis. Kidney Int 1999; 56: 2220.
9. Choi M, Ja E, Gimenez L, et al. Mycophenolate mofetil treatment for primary glomerular diseases. Kidney Int 2002; 61: 1098.
10. Daniel C, Ziswiler R, Frey B, Pfister M, Marti H. Proinflammatory effects in experimental mesangial proliferative glomerulonephritis of the immunosuppressive agent SDZ RAD, a rapamycin derivative. Exp Nephrol 2000; 8: 52.